Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of Q fever is assessed at USD 548.92 million. The growth of the market can be ascribed to factors, such as, increasing patient pool owing to the higher prevalence of Q fever, growing demand for enhanced diagnostic solutions, and raising awareness of acute & chronic Q fever prevention. Q fever, also designated as Query fever, is an infectious fever that can spread via contact with farm animals, such as, sheep, cattle, and others. Moreover, based on a report published by the National Library of Medicine (NLM) in 2020, about 50 people out of 100,000 suffer from acute Q fever annually while 1 person out of 1,000,000 obtains chronic Q fever in one year. Furthermore, people with low immunity, farmworkers, and old age people are more likely to get Q fever. As per data provided by World Bank, in 2020, 723,484,050 people were stated to be aged 65 years or above. All these factors are projected to influence the global Q fever market positively during the forecast period.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
5.1% |
|
Base Year Market Size (2023) |
USD 527.4 million |
|
Forecast Year Market Size (2036) |
USD 1 billion |
|
Regional Scope |
|
The market is segmented by type into acute and chronic, out of which, the acute segment is anticipated to hold the notable share in the Q fever market during the forecast period, on account of growing cases of acute Q fever. People obtain acute Q fever more frequently since it develops within 2-3 weeks. A higher patient pool of acute Q fever can be observed worldwide. Therefore, the segment is estimated to grow rapidly over the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Diagnosis |
|
|
By Application |
|
Regionally, the global Q fever market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region. The rising cases of diseases related to acute Q fever, such as, Rocky Mountain spotted fever, West Nile virus, and Lyme disease are observed in the region which is further estimated to hike the growth of the market in the region over the forecast period. According to data released by the Centers for Disease Control and Prevention (CDC), in 2019, 178 cases of acute Q fever, and 34 cases of chronic Q fever were reported in the United States. These are the significant factors to boost the growth of the market in the region. Furthermore, the global Q fever market is also projected to witness modest growth in the Asia Pacific region over the forecast period on the back of the growing number of cattle, increasing geriatric population with low immunity, and rising cases of Q fever. For instance, about 20% of Indians suffer from low immunity.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?